Cat#: | RP-1727H |
Product Name: | Recombinant Human VEGF-B / VEGFB Protein (Fc Tag) |
Synonym: | VEGFL,VRF |
Description: | A DNA sequence encoding the human VEGFB protein (NP_003368.1) (Pro22-Ala207) was expressed with the Fc region of human IgG1 at the N-terminus.The human VEGFB protein is purified by our unique chromatographic techniques. |
Source: | Human Cells |
Predicted N Terminal: | Glu |
Molecular Characterization: | The recombinant human VEGFB protein consists 446 amino acids and predicts a molecular mass of 47.8 kDa. |
Purity: | Greater than (75.2+22) % as determined by SDS-PAGE. |
Endotoxin: | < 1.0 EU per ug of recombinant human VEGFB protein as determined by the LAL method. |
Bioactivity: | Please contact us for detailed information |
Formulation: | Recombinant human VEGFB protein was lyophilized from sterile PBS, pH 7.4. |
Stability: | Recombinant human VEGFB Proteins are stable for up to 1 year from date of receipt at -70℃ |
Reconstitution: | Please see related COA for specific instructions. |
Storage: | Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃). |
References: | Poesen K, Lambrechts D, etc. "Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration". J. Neurosci. 28 (42): 10451–9. |